Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
3.080
+0.070 (2.33%)
At close: Feb 21, 2025, 4:00 PM
3.090
+0.010 (0.32%)
After-hours: Feb 21, 2025, 7:32 PM EST
Pliant Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | - | 1.58 | 9.69 | 7.57 | 41.82 | 57.05 | |
| Revenue Growth (YoY) | - | -83.69% | 27.91% | -81.89% | -26.70% | - | |
| Gross Profit | - | 1.58 | 9.69 | 7.57 | 41.82 | 57.05 | |
| Selling, General & Admin | 58.38 | 57.93 | 39.95 | 27.56 | 17.27 | 10.93 | |
| Research & Development | 163.7 | 127.8 | 96.94 | 77.55 | 66.19 | 47.35 | |
| Operating Expenses | 222.08 | 185.73 | 136.89 | 105.11 | 83.46 | 58.28 | |
| Operating Income | -222.08 | -184.15 | -127.2 | -97.54 | -41.65 | -1.23 | |
| Interest Expense | -2.51 | -1.27 | -0.79 | - | - | - | |
| Interest & Investment Income | 22.91 | 24.08 | 4.67 | 0.27 | 0.11 | 0.6 | |
| Pretax Income | -201.68 | -161.34 | -123.32 | -97.26 | -41.53 | -0.63 | |
| Net Income | -201.68 | -161.34 | -123.32 | -97.26 | -41.53 | -0.63 | |
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 6.23 | |
| Net Income to Common | -201.68 | -161.34 | -123.32 | -97.26 | -41.53 | -6.86 | |
| Shares Outstanding (Basic) | 60 | 59 | 42 | 36 | 21 | 2 | |
| Shares Outstanding (Diluted) | 60 | 59 | 42 | 36 | 21 | 2 | |
| Shares Change (YoY) | 7.77% | 39.75% | 17.21% | 67.94% | 1214.82% | 39.29% | |
| EPS (Basic) | -3.34 | -2.75 | -2.94 | -2.71 | -1.95 | -4.22 | |
| EPS (Diluted) | -3.34 | -2.75 | -2.94 | -2.71 | -1.95 | -4.22 | |
| Free Cash Flow | -136.64 | -117.28 | -96.39 | -77.4 | -38.8 | -3.71 | |
| Free Cash Flow Per Share | -2.27 | -2.00 | -2.29 | -2.16 | -1.82 | -2.29 | |
| Gross Margin | - | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | |
| Operating Margin | - | -11654.75% | -1313.37% | -1288.10% | -99.59% | -2.16% | |
| Profit Margin | - | -10211.14% | -1273.32% | -1284.51% | -99.32% | -12.02% | |
| Free Cash Flow Margin | - | -7422.91% | -995.26% | -1022.13% | -92.79% | -6.51% | |
| EBITDA | -219.95 | -182.3 | -125.38 | -96 | -40.34 | -0.12 | |
| EBITDA Margin | - | - | - | - | -96.46% | -0.21% | |
| D&A For EBITDA | 2.13 | 1.84 | 1.82 | 1.54 | 1.31 | 1.11 | |
| EBIT | -222.08 | -184.15 | -127.2 | -97.54 | -41.65 | -1.23 | |
| EBIT Margin | - | - | - | - | -99.59% | -2.16% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.